Alessio Nocentini

Alessio Nocentini

Università degli Studi di Firenze

H-index: 43

Europe-Italy

About Alessio Nocentini

Alessio Nocentini, With an exceptional h-index of 43 and a recent h-index of 40 (since 2020), a distinguished researcher at Università degli Studi di Firenze, specializes in the field of Medicinal Chemistry, Drug Design, Organic Chemistry, Computational Chemistry, Enzymatic Evaluation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma

Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial …

Thiochromenocarbazole imide-based photosensitizers decorated with carbonic anhydrase inhibitors for the targeted treatment of hypoxic tumours

Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains

Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases

Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII

Alessio Nocentini Information

University

Position

NEUROFARBA Dept.

Citations(all)

5999

Citations(since 2020)

5631

Cited By

2212

hIndex(all)

43

hIndex(since 2020)

40

i10Index(all)

165

i10Index(since 2020)

164

Email

University Profile Page

Università degli Studi di Firenze

Google Scholar

View Google Scholar Profile

Alessio Nocentini Skills & Research Interests

Medicinal Chemistry

Drug Design

Organic Chemistry

Computational Chemistry

Enzymatic Evaluation

Top articles of Alessio Nocentini

Title

Journal

Author(s)

Publication Date

Leveraging SARS-CoV-2 Main Protease (Mpro) for COVID-19 Mitigation with Selenium-Based Inhibitors

International Journal of Molecular Sciences

Viviana De Luca

Andrea Angeli

Alessio Nocentini

Paola Gratteri

Silvia Pratesi

...

2024/1/12

Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma

Journal of Medicinal Chemistry

Haytham O Tawfik

Mohamed M Saleh

Andrea Ammara

Eman F Khaleel

Rehab Badi

...

2024/1/11

Dual Inhibitors of Brain Carbonic Anhydrases and Monoamine Oxidase-B Efficiently Protect against Amyloid-β-Induced Neuronal Toxicity, Oxidative Stress, and Mitochondrial …

Journal of Medicinal Chemistry

Simone Giovannuzzi

Daniel Chavarria

Gustavo Provensi

Manuela Leri

Monica Bucciantini

...

2024/3/4

Thiochromenocarbazole imide-based photosensitizers decorated with carbonic anhydrase inhibitors for the targeted treatment of hypoxic tumours

Materials Advances

Amina Merabti

Darío Puchán Sánchez

Alessio Nocentini

Lamiaa MA Ali

Christophe Nguyen

...

2024

Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains

International Journal of Molecular Sciences

Silvia Bua

Alessandro Bonardi

Georgiana Ramona Mük

Alessio Nocentini

Paola Gratteri

...

2024/2/23

Coumarins-lipophilic cations conjugates: Efficient mitocans targeting carbonic anhydrases

Bioorganic Chemistry

Alma Fuentes-Aguilar

Aday González-Bakker

Mirna Jovanović

Sofija Jovanović Stojanov

Adrián Puerta

...

2024/2/6

Design, synthesis, and carbonic anhydrase inhibition activities of Schiff bases incorporating benzenesulfonamide scaffold: Molecular docking application

Saudi Pharmaceutical Journal

Adel S El-Azab

A-M Alaa

Silvia Bua

Alessio Nocentini

Ahmed H Bakheit

...

2023/12/1

Antihistamines, phenothiazine-based antipsychotics, and tricyclic antidepressants potently activate pharmacologically relevant human carbonic anhydrase isoforms II and VII

Journal of Enzyme Inhibition and Medicinal Chemistry

Francesco Fiorentino

Alessio Nocentini

Dante Rotili

Claudiu T Supuran

Antonello Mai

2023/12/31

Pyrrolyl and Indolyl α-γ-Diketo Acid Derivatives Acting as Selective Inhibitors of Human Carbonic Anhydrases IX and XII

Pharmaceuticals

Davide Ialongo

Antonella Messore

Valentina Noemi Madia

Valeria Tudino

Alessio Nocentini

...

2023/1/27

mGluR5 PAMs rescue cortical and behavioural defects in a mouse model of CDKL5 deficiency disorder

Neuropsychopharmacology

Antonia Gurgone

Riccardo Pizzo

Alessandra Raspanti

Giuseppe Chiantia

Sunaina Devi

...

2023/5

Aryl derivatives of 3H-1,2-benzoxaphosphepine 2-oxides as inhibitors of cancer-related carbonic anhydrase isoforms IX and XII

Journal of Enzyme Inhibition and Medicinal Chemistry

Anastasija Balašova

Aleksandrs Pustenko

Alessio Nocentini

Daniela Vullo

Claudiu T Supuran

...

2023/12/31

1, 5-diaryl-1, 2, 4-triazole ureas as new SLC-0111 analogues endowed with dual carbonic anhydrase and VEGFR-2 inhibitory activities

Journal of Medicinal Chemistry

Ahmed E Elsawi

Mostafa M Elbadawi

Alessio Nocentini

Hadia Almahli

Simone Giovannuzzi

...

2023/7/28

Boron-containing carbonic anhydrases inhibitors

Simone Giovannuzzi

Anna Nikitjuka

Bruna Rafaela Pereira Resende

Michael Smietana

Alessio Nocentini

...

2023/11/19

Diversely N-substituted benzenesulfonamides dissimilarly bind to human carbonic anhydrases: crystallographic investigations of N-nitrosulfonamides

Journal of Enzyme Inhibition and Medicinal Chemistry

Andrea Angeli

Marta Ferraroni

Alessandro Bonardi

Claudiu T Supuran

Alessio Nocentini

2023/12/31

Development of potent nanosized carbonic anhydrase inhibitor for targeted therapy of hypoxic solid tumors

International Journal of Pharmaceutics

Wagdy M Eldehna

Mahmoud A El Hassab

Nahla A Abdelshafi

Rana A Eissa

Nadeen H Diab

...

2023/1/25

Atropo/Tropo Flexibility: A Tool for Design and Synthesis of Self-Adaptable Inhibitors of Carbonic Anhydrases and Their Antiproliferative Effect

Journal of Medicinal Chemistry

Jekateri̅na Ivanova

Alessio Nocentini

Kaspars Tars

Ja̅nis Leita̅ns

Elviss Dvinskis

...

2023/4/6

Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment

Journal of Endocrinological Investigation

L Fei

G Cantini

A Nocentini

P Nardini

S Catarinicchia

...

2023/7

Discovery of indolinone-bearing benzenesulfonamides as new dual carbonic anhydrase and VEGFR-2 inhibitors possessing anticancer and pro-apoptotic properties

European Journal of Medicinal Chemistry

Samaa Saied

Moataz Shaldam

Mostafa M Elbadawi

Simone Giovannuzzi

Alessio Nocentini

...

2023/11/5

Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry

Simone Giovannuzzi

Alessandro Bonardi

Paola Gratteri

Alessio Nocentini

Claudiu T Supuran

2023/12/31

Discovery of new 6-ureido/amidocoumarins as highly potent and selective inhibitors for the tumour-relevant carbonic anhydrases IX and XII

Journal of Enzyme Inhibition and Medicinal Chemistry

Ashraf K El-Damasy

Hyun Ji Kim

Alessio Nocentini

Seon Hee Seo

Wagdy M Eldehna

...

2023/12/31

See List of Professors in Alessio Nocentini University(Università degli Studi di Firenze)

Co-Authors

H-index: 164
Claudiu T. Supuran

Claudiu T. Supuran

Università degli Studi di Firenze

H-index: 54
Jean-Yves Winum

Jean-Yves Winum

Université de Montpellier

H-index: 43
Wagdy M. Eldehna

Wagdy M. Eldehna

Kafrelsheikh University

H-index: 31
Silvia Bua

Silvia Bua

Università degli Studi di Firenze

academic-engine